WHO expects hydroxychloroquine safety findings by mid-June

Credit: Reuters- Published on May 26, 2020
The World Health Organization (WHO) on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug's use in a trial on COVID-19 patients.
Advertisement

Video credit: Wochit
Published on May 26, 2020 -  00:42
WHO Expects Hydroxychloroquine Safety Findings In June
The World Health Organization on Tuesday promised a swift review of data on hydroxychloroquine. This review should be available probably by mid-June, reports Reuters. Safety concerns prompted the group to suspend the malaria drug’s use in a large trial on COVID-19 patients. A final decision on the harm, benefit or lack of benefit will be made once the evidence is reviewed. There are already 17 countries currently studying it under a group called Solidarity. Separate hydroxychloroquine trials include a 440-patient U.S. study are continuing enrollment.

You are here

You might like